FR2834892B1 - Composition pharmaceutique orodispersible de mitiglinide - Google Patents

Composition pharmaceutique orodispersible de mitiglinide

Info

Publication number
FR2834892B1
FR2834892B1 FR0200794A FR0200794A FR2834892B1 FR 2834892 B1 FR2834892 B1 FR 2834892B1 FR 0200794 A FR0200794 A FR 0200794A FR 0200794 A FR0200794 A FR 0200794A FR 2834892 B1 FR2834892 B1 FR 2834892B1
Authority
FR
France
Prior art keywords
mitiglinide
pharmaceutical composition
orodispersible pharmaceutical
orodispersible
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0200794A
Other languages
English (en)
Other versions
FR2834892A1 (fr
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Priority to FR0200794A priority Critical patent/FR2834892B1/fr
Priority to ARP030100179A priority patent/AR038208A1/es
Priority to PCT/FR2003/000196 priority patent/WO2003061650A1/fr
Publication of FR2834892A1 publication Critical patent/FR2834892A1/fr
Application granted granted Critical
Publication of FR2834892B1 publication Critical patent/FR2834892B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
FR0200794A 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de mitiglinide Expired - Fee Related FR2834892B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0200794A FR2834892B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de mitiglinide
ARP030100179A AR038208A1 (es) 2002-01-23 2003-01-22 Composicion farmaceutica dispersable oralmente de mitiglinida
PCT/FR2003/000196 WO2003061650A1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible de mitiglinide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200794A FR2834892B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de mitiglinide

Publications (2)

Publication Number Publication Date
FR2834892A1 FR2834892A1 (fr) 2003-07-25
FR2834892B1 true FR2834892B1 (fr) 2004-02-27

Family

ID=27589558

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200794A Expired - Fee Related FR2834892B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de mitiglinide

Country Status (3)

Country Link
AR (1) AR038208A1 (fr)
FR (1) FR2834892B1 (fr)
WO (1) WO2003061650A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004002474A1 (ja) * 2002-06-28 2005-10-27 キッセイ薬品工業株式会社 糖尿病性合併症の予防又は進展阻止用医薬組成物
CA2658549A1 (fr) * 2006-08-08 2008-02-14 Kissei Pharmaceutical Co., Ltd. Comprime a desagregation orale ayant un gout amer masque et son procede de production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
CA2179382C (fr) * 1994-01-31 2009-11-10 Takao Mizumoto Produits moules comprimes se dissolvant dans la bouche et procede de fabrication
FR2765578B1 (fr) * 1997-07-03 1999-09-10 Adir Procede de preparation d'un perhydroisoindole substitue
ATE371439T1 (de) * 2000-07-27 2007-09-15 Roquette Freres Granulat bestehend aus stärke und laktose

Also Published As

Publication number Publication date
FR2834892A1 (fr) 2003-07-25
WO2003061650A1 (fr) 2003-07-31
AR038208A1 (es) 2005-01-05

Similar Documents

Publication Publication Date Title
FR2834890B1 (fr) Composition pharmaceutique orodispersible d'agomelatine
FI20011478A (fi) Farmaseuttinen koostumus
PT1066027E (pt) Composicao farmaceutica de topiramato
IS2580B (is) Platínuafleiða lyfjasamsetningar
PT1501534E (pt) Formulacoes farmaceuticas
NO20033556L (no) Farmasöytiske formuleringer
IS7714A (is) Lyfjasamsetningar úr módafíníl
DK1395242T3 (da) Flydende farmaceutisk sammensætning
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
EE200200393A (et) Glüburiidi ravimkoostis
EE200300589A (et) Ravimkoostised
FI20022128A (fi) Farmaseuttinen koostumus
FR2834893B1 (fr) Composition pharmaceutique orodispersible de perindopril
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
FR2834896B1 (fr) Composition pharmaceutique orodispersible d'ivabradine
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
FR2834892B1 (fr) Composition pharmaceutique orodispersible de mitiglinide
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
NO20033073L (no) Farmasöytisk sammensetning inneholdende citalopram
FR2834894B1 (fr) Composition pharmaceutique orodispersible de piribedil
FR2834897B1 (fr) Composition pharmaceutique orodispersible de testosterone
NO20042074L (no) Makrolider inneholdende farmasoytiske sammensetninger
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20044164L (no) Farmasoytiske sammensetninger

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070930